Australia markets closed
  • ALL ORDS

    7,557.80
    -29.60 (-0.39%)
     
  • AUD/USD

    0.7173
    +0.0040 (+0.56%)
     
  • ASX 200

    7,235.90
    -20.10 (-0.28%)
     
  • OIL

    68.41
    +2.23 (+3.37%)
     
  • GOLD

    1,788.70
    +12.20 (+0.69%)
     
  • BTC-AUD

    79,234.24
    +185.88 (+0.24%)
     
  • CMC Crypto 200

    1,463.46
    +20.68 (+1.43%)
     

23andMe Stock Could Be a Big Winner If This 1 Thing Happens

·5-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

In June, 23andMe (NASDAQ: ME) officially finished the process of going public via a special purpose acquisition company (SPAC). While no one knows where shares of the genetic-testing company will trade in the near term, investors have a better idea of where 23andMe stock can trade over the long term. Over the course of years, stock prices tend to correlate with cash flows and, therefore, if the company dramatically increases it cash flows, the stock price could head higher as well.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting